Autopsy and Case Reports
https://www.autopsyandcasereports.org/article/doi/10.4322/acr.2021.268
Autopsy and Case Reports
Autopsy Case Report

Neonatal acute liver failure with pulmonary yellow hyaline membrane and kernicterus

Kei Shing Oh; Hisham F. Bahmad; Carole Brathwaite; Amilcar Castellano Sanchez; Monica Recine

Downloads: 4
Views: 1013

Abstract

Background: Neonatal acute liver failure (NALF) is a rare and life-threatening condition. It causes bilirubin to accumulate to a dangerous level in the body, causing permanent damage to vital organs such as the brain and lungs. In many cases, the etiology of NALF remains unknown.

Case presentation: We described a case of an 8-day-old baby girl who presented with poor oral intake, lethargy, and jaundice. Her clinical condition rapidly deteriorated with progression to multi-organ failure, and despite intensive resuscitation efforts, she expired. At autopsy, the most significant findings were liver necrosis, yellow hyaline membrane deposition in the lungs, and bilirubin deposition in the brain (kernicterus).

Conclusions: NALF is a rare and potentially fatal condition necessitating prompt recognition and disease-specific treatment approaches. Toxic accumulation of bilirubin in the lungs can lead to hypoxia and precipitate further ischemic injury to the liver.

Keywords

Bilirubin, Kernicterus, Brain, Lung

References

1 Larson-Nath C, Vitola BE. Neonatal acute liver failure. Clin Perinatol. 2020;47(1):25-39. http://dx.doi.org/10.1016/j.clp.2019.10.006. PMid:32000927.

2 Taylor SA, Whitington PF. Neonatal acute liver failure. Liver Transpl. 2016;22(5):677-85. http://dx.doi.org/10.1002/lt.24433. PMid:26946058.

3 Squires RH Jr, Shneider BL, Bucuvalas J, et al. Acute liver failure in children: the first 348 patients in the pediatric acute liver failure study group. J Pediatr. 2006;148(5):652-8.e2. http://dx.doi.org/10.1016/j.jpeds.2005.12.051. PMid:16737880.

4 Bonilla S, Prozialeck JD, Malladi P, et al. Neonatal iron overload and tissue siderosis due to gestational alloimmune liver disease. J Hepatol. 2012;56(6):1351-5. http://dx.doi.org/10.1016/j.jhep.2012.01.010. PMid:22322235.

5 Abdullatif H, Mohsen N, El-Sayed R, El-Mougy F, El-Karaksy H. Haemophagocytic lymphohistiocytosis presenting as neonatal liver failure: a case series. Arab J Gastroenterol. 2016;17(2):105-9. http://dx.doi.org/10.1016/j.ajg.2016.06.002. PMid:27397412.

6 Sundaram SS, Alonso EM, Narkewicz MR, Zhang S, Squires RH. Characterization and outcomes of young infants with acute liver failure. J Pediatr. 2011;159(5):813-8.e1. http://dx.doi.org/10.1016/j.jpeds.2011.04.016. PMid:21621221.

7 Henter JI, Horne A, Aricó M, et al. HLH-2004: diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis. Pediatr Blood Cancer. 2007;48(2):124-31. http://dx.doi.org/10.1002/pbc.21039. PMid:16937360.

8 Reddy DK, Pandey S. Kernicterus. Florida: StatPearls; 2020.

9 Valdés-Dapena MA, Nissim JE, Arey JB, Godleski J, Schaaf HD, Haust MD. Yellow pulmonary hyaline membranes. J Pediatr. 1976;89(1):128-32. http://dx.doi.org/10.1016/S0022-3476(76)80947-X. PMid:932882.

10 Turkel SB, Mapp JR. A ten-year retrospective study of pink and yellow neonatal hyaline membrane disease. Pediatrics. 1983;72(2):170-5. PMid:6866601.

11 Ivanova V, Brainova-Michich I. History or “rise and fall” of yellow hyaline membrane disease. Sci Technol. 2016;6:340-4.

12 Morgenstern B, Klionsky B, Doshi N. Yellow hyaline membrane disease. Identification of the pigment and bilirubin binding. Lab Invest. 1981;44(6):514-8. PMid:6164874.

13 Doshi N, Klionsky B, Fujikura T, MacDonald H. Pulmonary yellow hyaline membranes in neonates. Hum Pathol. 1980;11(5, Suppl):520-7. PMid:7429502.
 


Submitted date:
02/04/2021

Accepted date:
02/19/2021

Publication date:
05/06/2021

6094449fa953951e55343716 autopsy Articles
Links & Downloads

Autops Case Rep

Share this page
Page Sections